Clinical Trials Logo

Social Function clinical trials

View clinical trials related to Social Function.

Filter by:
  • None
  • Page 1

NCT ID: NCT03972735 Recruiting - Schizophrenia Clinical Trials

Assessment of the Effectiveness of the NECT Program

NECT
Start date: February 10, 2020
Phase: N/A
Study type: Interventional

Self-stigma refers to the transformation process wherein a person's previously held social identity is progressively replaced by a devalued and stigmatized view of oneself termed "illness identity". Self-Stigma is a severe problem in Serious Mental Illness (SMI). Self-stigma prevalence is high (41.7% of the 1229 participants with SZ and 21.7% of the 1182 participants with mood disorders had moderate to high levels of IS in the GAMIAN-Europe study). Self-stigma was negatively associated with self-esteem, social function, wellbeing, quality of life or personal recovery and positively associated with psychiatric symptoms and depression. Several psychosocial interventions (mostly combinations of psychoeducation and cognitive behaviour therapy) have been designed to reduce self-stigma and its impact on clinical and functional outcomes, with preliminary effects on self-stigma, insight and self-efficacy. Narrative Enhancement and Cognitive Therapy (NECT) is a manualized structured 20-session group-based intervention . Conducted by two trained facilitators the sessions combine psychoeducation, cognitive restructuring and story-telling exercises to reduce self-stigma. Developed in USA, NECT was adapted in Israel and Sweden. NECT showed effectiveness in reducing self-stigma and in improving self-esteem and quality of life. Despite being effective on changing coping strategies, NECT effectiveness on social function is still unclear. The present study aims to validate NECT French adaptation and to evaluate its effectiveness on social function, self-stigma, psychiatric symptoms, self-esteem, wellbeing, quality of life and personal recovery in SMI participants (schizophrenia, bipolar disorder, borderline personality disorder)

NCT ID: NCT03784222 Terminated - Clinical trials for First Episode Schizophrenia

Effects on Social and Cognition Functions of Blonanserin in First Episode Schizophrenia Patients

Start date: January 22, 2019
Phase: Phase 4
Study type: Interventional

This is an open label, multi-center study to explore the effects on social functions of blonanserin in first episode schizophrenia patients